TREM2 as a Therapeutic Target in Atherosclerosis

Siting Xu1, Bo Yang1, Wenhua Yu1

  • 1Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.

PubMed
Summary

Triggering receptor expressed on myeloid cells-2 (TREM2) is crucial for foamy macrophage survival and atherosclerosis progression. Targeting TREM2 offers a potential therapeutic strategy for treating atherosclerosis.